相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Identification of genetic markers in Sodium Antimony Gluconate (SAG) sensitive and resistant Indian clinical isolates of Leishmania donovani through amplified fragment length polymorphism (AFLP)
Awanish Kumar et al.
ACTA TROPICA (2009)
Parasite Susceptibility to Amphotericin B in Failures of Treatment for Visceral Leishmaniasis in Patients Coinfected with HIV Type 1 and Leishmania infantum
Laurence Lachaud et al.
CLINICAL INFECTIOUS DISEASES (2009)
Sub-optimal dose of Sodium Antimony Gluconate (SAG)-diperoxovanadate combination clears organ parasites from BALB/c mice infected with antimony resistant Leishmania donovani by expanding antileishmanial T-cell repertoire and increasing IFN-γ to IL-10 ratio
Arun Kumar Haldar et al.
EXPERIMENTAL PARASITOLOGY (2009)
Miltefosine Promotes IFN-gamma-Dominated Anti-Leishmanial Immune Response
Pallavi Wadhone et al.
JOURNAL OF IMMUNOLOGY (2009)
Paromomycin: Uptake and resistance in Leishmania donovani
Anupam Jhingran et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2009)
Leishmania commandeers the host inflammatory response through neutrophils
Ryan C. Jochim et al.
TRENDS IN PARASITOLOGY (2009)
Roles of trypanothione S-transferase and tryparedoxin peroxidase in resistance to antimonials
Susan Wyllie et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Characterization of an ABCG-like transporter from the protozoan parasite Leishmania with a role in drug resistance and transbilayer lipid movement
Esther Castanys-Munoz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
New treatment approach in Indian visceral leishmaniasis: Single-dose liposomal amphotericin B followed by short-course oral miltefosine
Shyam Sundar et al.
CLINICAL INFECTIOUS DISEASES (2008)
The relationship between leishmaniasis and AIDS: the second 10 years
Jorge Alvar et al.
CLINICAL MICROBIOLOGY REVIEWS (2008)
Identification of a Leishmania infantum gene mediating resistance to miltefosine and SbIII
Kohelia Choudhury et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2008)
Antileishmanial activity of nano-amphotericin B deoxycholate
Krishna Das Manandhar et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Amphotericin B formulations and drug targeting
J. J. Torrado et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
Miltefosine for visceral leishmaniasis relapse treatment and secondary prophylaxis in HIV-infected patients
Nuno Marques et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2008)
Drug regimens for visceral leishmaniasis in Mediterranean countries
Luigi Gradoni et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2008)
Inhibition of ABC transporters abolishes antimony resistance in Leishmania infection
Jayati Mookerjee Basu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Neutrophils contribute to development of a protective immune response during onset of infection with Leishmania donovani
Emma McFarlane et al.
INFECTION AND IMMUNITY (2008)
Hybrid cell vaccination resolves Leishmania donovani infection by eliciting a strong CD8+ cytotoxic T-lymphocyte response with concomitant suppression of interleukin-10 (IL-10) but not IL-4 or IL-13
Raiatava Basu et al.
INFECTION AND IMMUNITY (2007)
Epidemiology and Clinical Features of Patients with Visceral Leishmaniasis Treated by an MSF Clinic in Bakool Region, Somalia, 2004-2006
Marie-Eve Raguenaud et al.
PLOS NEGLECTED TROPICAL DISEASES (2007)
In vitro effect of new formulations of amphotericin B on amastigote and promastigote forms of Leishmania infantum
Lara Ordonez-Gutierrez et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
Inactivation of the miltefosine transporter, LdMT, causes miltefosine resistance that is conferred to the amastigote stage of Leishmania donovani and persists in vivo
Karin Seifert et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
Amphotericin B treatment for Indian visceral leishmaniasis: Response to 15 daily versus alternate-day infusions
Shyam Sundar et al.
CLINICAL INFECTIOUS DISEASES (2007)
Phase 4 trial of miltefosine for the treatment of Indian visceral leishmaniasis
Sujit Kumar Bhattacharya et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Injectable paromomycin for visceral leishmaniasis in India
Shyam Sundar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Possibility of membrane modification as a mechanism of antimony resistance in Leishmania donovani
Hema Kothari et al.
PARASITOLOGY INTERNATIONAL (2007)
Flavonoid dimers as bivalent modulators for pentamidine and sodium stiboglucanate resistance in Leishmania
Iris L. K. Wong et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Leishmania infantum:: Mixed T-helper-1/T-helper-2 immune response in experimentally infected BALB/c mice
Nuno Rolao et al.
EXPERIMENTAL PARASITOLOGY (2007)
Role of ABC transporter MRPA, γ-glutamylcysteine synthetase and ornithine decarboxylase in natural antimony-resistant isolates of Leishmania donovani
Angana Mukherjee et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Antileishmanial efficacy of amphotericin B bearing emulsomes against experimental visceral leishmaniasis
Swati Gupta et al.
JOURNAL OF DRUG TARGETING (2007)
Epidemiological dynamics of antimonial resistance in Leishmania donovani: Genotyping reveals a polyclonal population structure among naturally-resistant clinical isolates from Nepal
Thierry Laurent et al.
INFECTION GENETICS AND EVOLUTION (2007)
Interleukin-10 and the pathogenesis of human visceral leishmaniasis
Susanne Nylen et al.
TRENDS IN IMMUNOLOGY (2007)
Leishmania donovani:: An in vitro study of antimony-resistant amphotericin B-sensitive isolates
Abdalla Hassan Sharief et al.
EXPERIMENTAL PARASITOLOGY (2006)
Leishmania donovani:: Effect of verapamil on in vitro susceptibility of promastigote and amastigote stages of Indian clinical isolates to sodium stibogluconate
Ranjini Valiathan et al.
EXPERIMENTAL PARASITOLOGY (2006)
Combination of suboptimal doses of inhibitors targeting different domains of LtrMDR1 efficiently overcomes resistance of Leishmania spp. to miltefosine by inhibiting drug efflux
Jose M. Perez-Victoria et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Visceral leishmaniasis, or kala azar (KA): High incidence of refractoriness to antimony is contributed by anthroponotic transmission via post-KA dermal leishmaniasis
Ruchi Singh et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
A comparison of miltefosine and sodium stibogluconate for treatment of visceral leishmaniasis in an Ethiopian population with high prevalence of HIV infection
K Ritmeijer et al.
CLINICAL INFECTIOUS DISEASES (2006)
Mechanisms of experimental resistance of Leishmania to miltefosine:: Implications for clinical use
F. Javier Perez-Victoria et al.
DRUG RESISTANCE UPDATES (2006)
In vitro and in vivo interactions between miltefosine and other antileishmanial drugs
K Seifert et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Resistance of Leishmania donovani to sodium stibogluconate is related to the expression of host and parasite gamma-glutamylcysteine synthetase
KC Carter et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Gene expression analysis of the mechanism of natural Sb(V) resistance in Leishmania donovani isolates from Nepal
S Decuypere et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Alteration of fatty acid and sterol metabolism in miltefosine-resistant Leishmania donovani promastigotes and consequences for drug-membrane interactions
M Rakotomanga et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Refractoriness to the treatment of sodium stibogluconate in Indian kala-azar field isolates persist in in vitro and in vivo experimental models
A Dube et al.
PARASITOLOGY RESEARCH (2005)
Efficacy of picroliv in combination with miltefosine, an orally effective antileishmanial drug against experimental visceral leishmaniasis
S Gupta et al.
ACTA TROPICA (2005)
Dihidro-beta-agarofuran sesquiterpenes: A new class of reversal agents of the multidrug resistance phenotype mediated by P-glycoprotein in the protozoan parasite Leishmania
F Cortes-Selva et al.
CURRENT PHARMACEUTICAL DESIGN (2005)
Characterisation of Leishmania donovani promastigotes resistant to hexadecylphosphocholine (miltefosine)
K Seifert et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2003)
Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy
HW Murray et al.
INFECTION AND IMMUNITY (2002)
Low-dose liposomal amphotericin B in refractory Indian visceral leishmaniasis: A multicenter study
S Sundar et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2002)
Visceral leishmaniasis during childhood in southern Greece
HC Maltezou et al.
CLINICAL INFECTIOUS DISEASES (2000)
分享论文
